小结
定义
病史和体格检查
诊断性检查
治疗流程
撰稿人
作者
Professor of Medicine
Organizational Official for the Human Research Protection Program
Weill Cornell Medicine - Qatar
Doha
Qatar
利益声明
RAM is on speaker panels for Eli Lilly, Novo Nordisk, and Pfizer; he is on advisory boards for Novo Nordisk and Pfizer. RAM is an author of a number of references cited in this topic.
Speciality Registrar in Diabetes & Endocrinology and General Internal Medicine
University of Manchester
Manchester
UK
利益声明
UA serves on advisory boards for Eli Lilly.
SpR Diabetes and Endocrinology
Diabetes and Endocrinology
University of Manchester
Manchester
UK
利益声明
SA declares that she has no competing interests.
Dr Rayaz Malik, Dr Uazman Alam, and Dr Shazli Azmi would like to gratefully acknowledge Dr Rodica Pop-Busui and Dr Eva Feldman, the previous contributors to this topic.
利益声明
RPB declares that she has received speaking honoraria from Pfizer and research support from Amylin Pharmaceuticals; National Institutes of Health/National Heart, Lung, and Blood Institute; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases; American Diabetes Association; and Juvenile Diabetes Research Foundation. RPB and EF are authors of references cited in this topic.
同行评议者
Clinical Professor
Department of Medicine
Mount Sinai School of Medicine
New York
NY
利益声明
ZTB declares that he has no competing interests.
Assistant Professor of Medicine
Harvard Medical School
Division of Endocrinology
Diabetes and Hypertension
Brigham and Women's Hospital
Boston
MA
利益声明
RKG has received consultant fees from Aventis and Novartis, and speaker fees from Novartis.
Consultant and Honorary Senior Lecturer
Tameside General Hospital
Diabetes Centre
Ashton Under Lyne
Lancashire
UK
利益声明
EJ has received funding for conferences and lectures from Pfizer and Boehringer Ingelheim.
内容使用需遵循免责声明